| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018506 |
| Receipt No. | R000020542 |
| Scientific Title | Safety evaluation of an excessive consumption of a plant-derived processed product |
| Date of disclosure of the study information | 2015/07/31 |
| Last modified on | 2019/07/26 (Ver. 11) |
| Basic information | ||
| Public title | Safety evaluation of an excessive consumption of a plant-derived processed product | |
| Acronym | Safety evaluation a plant-derived processed product | |
| Scientific Title | Safety evaluation of an excessive consumption of a plant-derived processed product | |
| Scientific Title:Acronym | Safety evaluation a plant-derived processed product | |
| Region |
|
|
| Condition | ||
| Condition | Nothing (healty subject)
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of excessive consumption of a plant-derived processed product
|
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Safety evaluation (repeated ingestion for 4 weeks)
physical examination blood general analysis biochemical test urinalysis |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control food (product code ; C-001)
3 times of serving size per day for 4 weeks |
|
| Interventions/Control_2 | Test food (product code ; A-001)
3 times of serving size per day for 4 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1, BMI>=18.5 and <30 kg/m2
2, BMI>=20 and <65 years-old 3, Person who provides informed consent by a document |
|||
| Key exclusion criteria | 1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions.
2, Person who takes medication for glucose or fat metabolism, or hypertension. 3, Person who was given surgery for a disease or an injury 2 months prior to the study. 4, Individual intakes supplements or the food for specific use of health authorized the government. 5, Person had allergy against any constituents in the test diet. 6, Person who is used to take test food. 7, Individual experienced unpleasant feeling during blood drawing. 8, Person who donated 200mL or more of blood within a month prior to the study. 9, Heavy smoker 10, Person who don't record of meal recoding for 9 days 11, Shift worker 12, Person who is planned long term business trip or travel of a domestic or foreign country in study priod 13, Person who can't accept to be accessed their medical records. 14, Person who have participated in other clinical studies. 15, Person who are expecting pregnancy or lactation period. 16, Person who are considered inappropriate by medical doctors. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | KAO CORPORATION | ||||||
| Division name | Health Care Food Research Labs | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3 Bunka Sumida-ku Tokyo | ||||||
| TEL | 03-5630-7452 | ||||||
| katsuragi.yoshihisa@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | QOLRD CORPORATION | ||||||
| Division name | CRO Department | ||||||
| Zip code | 103-0027 | ||||||
| Address | 2-14-1 Nihonbashi Tyuo-ku Tokyo | ||||||
| TEL | 03-6386-8809 | ||||||
| Homepage URL | |||||||
| y-agawa@qol-rd.co.jp | |||||||
| Sponsor | |
| Institute | QOLRD CORPORATION |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KAO CORPORATION |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hasuda ishinkai clinic IRB |
| Address | 3-17 Honcho, Hasuda city, Saitama |
| Tel | 048-764-6411 |
| hs_iji2@hasuda-issinkai.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 蓮田一心会病院(埼玉県)、金沢文庫病院(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.lifescience.co.jp/yk/yk16/jun/ab4.html |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://www.lifescience.co.jp/yk/yk16/jun/ab4.html | ||||||
| Number of participants that the trial has enrolled | 60 | ||||||
| Results | Excessive consumption of test diets was safe |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | healthy subjects |
||||||
| Participant flow | 60 participants completed and 60 subjects were incorporated into the analyses |
||||||
| Adverse events | No adverse effect related to the test diets reported |
||||||
| Outcome measures | safety |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020542 |